Literature DB >> 18835060

Potential misclassification of patients with psoriasis in electronic databases.

Murat Icen1, Cynthia S Crowson, Marian T McEvoy, Sherine E Gabriel, Hilal Maradit Kremers.   

Abstract

BACKGROUND: Electronic claims and medical record databases are increasingly used for observational studies of psoriasis. The purpose of this study was to assess the validity of psoriasis diagnostic codes in an electronic database.
METHODS: This study was performed in a population-based setting in Olmsted County, Minnesota, where all diagnoses and procedures from all health care providers in a large community are indexed and recorded in an electronic database. The database was searched for patients aged 18 years or older with diagnostic codes consistent with psoriasis for the time period January 1, 1976, to January 1, 2000. The complete medical records of all patients were reviewed manually for validation of psoriasis diagnoses.
RESULTS: We reviewed the complete medical records of 2556 patients with at least one diagnostic code consistent with psoriasis. Based on medical record review, 1458 (57.0%) patients were confirmed to have psoriasis, of which the majority (81%) received confirmation by a dermatologist. The most commonly used diagnostic codes for psoriasis were International Classification of Diseases, Ninth Revision 696.1 (psoriasis, not otherwise specified) with a positive predictive value of 68.7% (95% confidence interval: 66.5%, 70.9%). Increasing frequency of codes in a given time window was associated with positive predictive values. However, positive predictive value for only one code in a 5-year time window was still as high as 60% (95% confidence interval: 57%, 63%). LIMITATIONS: Differences between individual electronic medical record databases may limit the ability to form a general conclusion from these findings. The remitting, relapsing course of psoriasis and the heterogeneity in clinical presentation create challenges in case ascertainment.
CONCLUSION: Electronic identification of patients with psoriasis by diagnostic codes alone may lead to misclassification in database studies.

Entities:  

Mesh:

Year:  2008        PMID: 18835060      PMCID: PMC2840380          DOI: 10.1016/j.jaad.2008.08.034

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  18 in total

1.  Coding errors: a comparative analysis of hospital and prospectively collected departmental data.

Authors:  H A Khwaja; H Syed; D W Cranston
Journal:  BJU Int       Date:  2002-02       Impact factor: 5.588

2.  Descriptive analyses of the integrity of a US Medicaid claims database.

Authors:  Sean Hennessy; Warren B Bilker; Anita Weber; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-03       Impact factor: 2.890

3.  Introduction to the mining of clinical data.

Authors:  James H Harrison
Journal:  Clin Lab Med       Date:  2008-03       Impact factor: 1.935

4.  Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study.

Authors:  Y B Brauchli; S S Jick; F Curtin; C R Meier
Journal:  Br J Dermatol       Date:  2008-04-10       Impact factor: 9.302

5.  Prevalence of cardiovascular risk factors in patients with psoriasis.

Authors:  Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2006-09-25       Impact factor: 11.527

6.  The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.

Authors:  Jonathan Shapiro; Arnon D Cohen; Michael David; Emilia Hodak; Gabi Chodik; Anna Viner; Eyal Kremer; Anthony Heymann
Journal:  J Am Acad Dermatol       Date:  2006-12-08       Impact factor: 11.527

7.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

8.  Association between psoriasis and the metabolic syndrome. A cross-sectional study.

Authors:  A D Cohen; M Sherf; L Vidavsky; D A Vardy; J Shapiro; J Meyerovitch
Journal:  Dermatology       Date:  2008-01-23       Impact factor: 5.366

9.  Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom.

Authors:  Joel M Gelfand; Jesse Berlin; Abby Van Voorhees; David J Margolis
Journal:  Arch Dermatol       Date:  2003-11

10.  Incidence and risk factors for psoriasis in the general population.

Authors:  Consuelo Huerta; Elena Rivero; Luis A García Rodríguez
Journal:  Arch Dermatol       Date:  2007-12
View more
  17 in total

1.  Risk and predictors of cardiovascular disease in psoriasis: a population-based study.

Authors:  Hilal Maradit-Kremers; Ross A Dierkhising; Cynthia S Crowson; Murat Icen; Floranne C Ernste; Marian T McEvoy
Journal:  Int J Dermatol       Date:  2013-01       Impact factor: 2.736

2.  The validity of the diagnostic code for hidradenitis suppurativa in an electronic database.

Authors:  G E Kim; J Shlyankevich; A B Kimball
Journal:  Br J Dermatol       Date:  2014-07-26       Impact factor: 9.302

3.  Association between psoriasis and incident cancer: the Iowa's Women's Health Study.

Authors:  Anna E Prizment; Alvaro Alonso; Aaron R Folsom; Rehana L Ahmed; Beth A Virnig; Erin M Warshaw; Kristin E Anderson
Journal:  Cancer Causes Control       Date:  2011-05-07       Impact factor: 2.506

4.  Comments on the Risk of Gout in Patients with Psoriasis [Letter].

Authors:  Wen-Bin Yeh; Wei-Kai Lee; Mei-Chia Chou; I-Ming Jou
Journal:  Clin Epidemiol       Date:  2022-07-15       Impact factor: 5.814

5.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

6.  Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.

Authors:  Maryam M Asgari; Jashin J Wu; Joel M Gelfand; Craig Salman; Jeffrey R Curtis; Leslie R Harrold; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-05-02       Impact factor: 2.890

7.  Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States.

Authors:  Lauren Kwa; Michael C Kwa; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2017-09-28       Impact factor: 11.527

8.  Validation of Psoriasis Diagnoses Recorded in Finnish Biobanks.

Authors:  Suvi Haverinen; Armi Vihervaara; Eliisa Löyttyniemi; Sirkku Peltonen; Leena Koulu; Kaisa Tasanen; Laura Huilaja
Journal:  Acta Derm Venereol       Date:  2020-10-21       Impact factor: 3.875

9.  Association between psoriasis, psoriatic arthritis and gastrointestinal disease : An exploratory nationwide inpatient sample analysis.

Authors:  Ahmed Yousaf; Rahul Raiker; Stephen M Davis; Swapna Gayam; Zachary Zinn
Journal:  Wien Klin Wochenschr       Date:  2020-09-23       Impact factor: 2.275

10.  Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use.

Authors:  Junko Takeshita; Joel M Gelfand; Penxiang Li; Lionel Pinto; Xinyan Yu; Preethi Rao; Hema N Viswanathan; Jalpa A Doshi
Journal:  J Invest Dermatol       Date:  2015-07-27       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.